Status:
UNKNOWN
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Sarcoma
Eligibility:
All Genders
Brief Summary
To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer
- Written informed consent
- body fluid derived from cancer, available for drainage and collection
Exclusion
- patients who do not give informed consent form for research use of biomaterials/biospecimens
Key Trial Info
Start Date :
August 31 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01831609
Start Date
August 31 2011
End Date
December 1 2024
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea